JC Chavez, S Dalia, J Sandoval-Sus… - … Myeloma and Leukemia, 2015 - Elsevier
Patients with chronic lymphocytic leukemia (CLL) have a 2-to 5-fold risk of developing a second malignancy compared with the general population. The incidence of myeloid …
E Smith, R Rottscholl, S Brosch… - Laryngo-Rhino …, 2013 - thieme-connect.com
Maligne hämatologische Erkrankungen, wie das hochmaligne diffuse großzellige B-Zell Non Hodgkin Lymphom, das MALT Lymphom und das extramedulläre Plasmozytom …
M Bernués, MA Durán, G Puget, J Iglesias… - Anticancer …, 2014 - ar.iiarjournals.org
Background: Patients affected by chronic lymphocytic leukemia (CLL) have an increased risk of developing a second cancer. There is not a definitive explanation for this …
L Li, L Hamilton, J Montgomery… - The Journal of …, 2020 - cambridge.org
BackgroundPatients with non-Hodgkin's lymphoma and chronic lymphocytic leukaemia are at an elevated risk of further malignancy. Head and neck squamous cell carcinoma often …
P Bhinder, M Chahin, L Zuberi - Journal of Investigative …, 2019 - journals.sagepub.com
Chronic lymphocytic leukemia (CLL) patients are at an increased risk for developing more aggressive lymphomas via Richter's transformation and of developing secondary …
UL DEMİR, M YÜKSEL, E ÖZTOSUN… - Journal of Ear Nose …, 2013 - search.proquest.com
Kronik lenfositik lösemi (KLL) en sık görülen lösemi tipi olup, oldukça farklı klinik seyir gösterebilir. KLL tanısı olan hastalar deri, akciğer ve gastrointestinal sistem kanserleri gibi …